<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11031309</article-id><article-id pub-id-type="pmcid-ver">PMC11031309.319</article-id><article-id pub-id-type="pmcaid">11031309</article-id><article-id pub-id-type="pmcaiid">11031309</article-id><article-id pub-id-type="manuscript-id">NIHMS1976716</article-id><article-id pub-id-type="pmid">38387256</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2024.111132</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1976716</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1976716</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Co-Delivery of HIV Pre-Exposure Prophylaxis (PrEP) and HIV testing Among Publicly Insured Adolescents and Young Adults (AYA) Receiving Medication for Opioid Use Disorder (MOUD)</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Herrera</surname><given-names initials="MC">MC</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Johnson</surname><given-names initials="J">J</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lim</surname><given-names initials="S">S</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Morales</surname><given-names initials="KH">KH</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilson</surname><given-names initials="JD">J Deanna</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hadland</surname><given-names initials="SE">SE</given-names></name><xref rid="A5" ref-type="aff">5</xref><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Metzger</surname><given-names initials="D">D</given-names></name><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wood</surname><given-names initials="S">S</given-names></name><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dowshen</surname><given-names initials="N">N</given-names></name><xref rid="A8" ref-type="aff">8</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Adolescent Medicine, Department of General Pediatrics, Children&#8217;s Hospital of Philadelphia, Philadelphia, PA.</aff><aff id="A2"><label>2</label>Department of Behavioral Health and Intellectual disAbility Services, Philadelphia, PA.</aff><aff id="A3"><label>3</label>Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.</aff><aff id="A4"><label>4</label>Department of Family Medicine and Community Health, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.</aff><aff id="A5"><label>5</label>Division of Adolescent and Young Adult Medicine, MassGeneral for Children / Harvard Medical School, Boston, MA.</aff><aff id="A6"><label>6</label>Department of Pediatrics, Harvard Medical School, Boston, MA</aff><aff id="A7"><label>7</label>Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.</aff><aff id="A8"><label>8</label>Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><bold>Contributors:</bold> All authors (Maria Christina Herrera, Jewell Johnson, Suet Lim, Knashawn Morales, Deanna Wilson, Scott Hadland, David Metzger, Sarah Wood and Nadia Dowshen) have read and approved this submission. Each has participated in the design, interpretation of data, drafting and revision of the manuscript, and agree that the manuscript accurately reflects the study results. Philadelphia Department of Public Health collaborators also read and approved this submission.</p></fn><corresp id="CR1"><bold>Corresponding Author:</bold> Maria Christina Herrera, MD MSHP, <bold>Permanent Address:</bold> 507 Captain&#8217;s Way, Philadelphia, PA 19146, <email>herreramc@email.chop.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P25"><bold>Conflict of Interest:</bold> None of the authors have any financial conflict to disclose.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>2</month><year>2024</year></pub-date><volume>257</volume><issue-id pub-id-type="pmc-issue-id">460477</issue-id><fpage>111132</fpage><lpage>111132</lpage><pub-history><event event-type="nihms-submitted"><date><day>29</day><month>03</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-01 00:25:45.780"><day>01</day><month>04</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1976716.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P2">Low rates of HIV pre-exposure prophylaxis (PrEP) prescribing contribute to the disproportionate burden of HIV in the United States. Among adolescent and young adults (AYA) with opioid use disorder, HIV testing and PrEP co-prescription rates are poorly characterized.</p></sec><sec id="S2"><title>Methods:</title><p id="P3">We performed a retrospective analysis involving deidentified data from Philadelphia&#8217;s Medicaid beneficiaries ages 16&#8211;29 years who were prescribed medication for opioid use disorder (MOUD) from 2015&#8211;2020 and continuously Medicaid-enrolled for &#8805;6 months prior to that prescription. After identifying the presence of a qualifying diagnosis signifying a PrEP indication, we examined the outcome of appropriate PrEP co-prescriptions and HIV testing using generalized estimating equations (GEE) modeling.</p></sec><sec id="S3"><title>Results:</title><p id="P4">We identified 795 AYA Medicaid beneficiaries with 1,269 qualified treatment episodes. We calculated a PrEP prescribing rate of 29.47 per 1,000 person-years among AYA receiving MOUD. The HIV testing rate was 63.47 per 1,000 person-years among AYA receiving MOUD. GEE modeling revealed that individuals receiving methadone were more likely (aOR=2.62, 95% CI=1.06&#8211;6.49) to receive HIV testing within 6 months after a PrEP-qualifying diagnosis compared to those receiving other MOUD medications. Those who only saw outpatient behavioral health providers were less likely (aOR=0.48, 95% CI=0.24&#8211;0.99) to have received an HIV test within 6 months after the PrEP-qualifying diagnosis compared to those receiving inpatient behavioral health services.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P5">Co-prescription of PrEP and HIV testing among AYA receiving MOUD was rare in this large urban publicly insured population. Interventions are needed to increase HIV prevention services for this key population of AYA at risk for HIV infection.</p></sec></abstract><kwd-group><kwd>Adolescent and Young Adult</kwd><kwd>MOUD</kwd><kwd>HIV</kwd><kwd>PrEP</kwd><kwd>Administrative Claims</kwd><kwd>Generalized Estimating Equations</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>